MeiraGTx (NASDAQ:MGTX) Clears Minervini Trend Template and High-Growth Momentum Screen
RBC Capital Maintains Outperform on MeiraGTx Holdings, Raises Price Target to $27
MeiraGTx Hldgs Q2 EPS $1.71 Beats $(0.46) Estimate, Sales $321.434M Beat $12.476M Estimate
MeiraGTx Hldgs Q2 Sales $321.434M Beat $12.476M Estimate
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last?
RBC Capital Maintains Outperform on MeiraGTx Holdings, Raises Price Target to $26
HC Wainwright & Co. Reiterates Buy on MeiraGTx Holdings, Maintains $20 Price Target
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
MeiraGTx Signs Agreement With Oberland Capital Management For Investment Of $400M In Co.
MeiraGTx: The Market Is Missing The Manufacturing Pivot
MeiraGTx Holdings plc (MGTX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
MeiraGTx Holdings plc (MGTX) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint
Here's What Analysts Are Forecasting For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its First-Quarter Results
RBC Capital Maintains Outperform on MeiraGTx Holdings, Raises Price Target to $25
MeiraGTx Holdings plc (MGTX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MeiraGTx Holdings (NASDAQ:MGTX) Passes Minervini Trend Template and High Growth Momentum Screen
MeiraGTx Hldgs Q1 EPS $(0.57) Misses $(0.44) Estimate, Sales $293.000K Miss $13.913M Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.